Back to Search
Start Over
Successful Granulocyte Colony-stimulating Factor Treatment of Relapsing Candida albicans Meningoencephalitis Caused by CARD9 Deficiency.
- Source :
-
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2016 Apr; Vol. 35 (4), pp. 428-31. - Publication Year :
- 2016
-
Abstract
- Caspase-associated recruitment domain-9 (CARD9) deficiency is an autosomal-recessive primary immunodeficiency with genetic defects in Th17 immunity marked by susceptibility to recurrent and invasive Candida infections. We present a case of relapsing Candida albicans meningoencephalitis over 1-year period despite appropriate antifungal therapy. We detected a homozygous p.Q295X mutation in CARD9 as well as a defective interleukin-17 and interferon gamma synthesis in Enzyme-Linked ImmunoSpot tests. We achieved complete clinical remission, and improvement of interleukin-17 secretion with subcutaneous granulocyte colony-stimulating factor) treatment.
- Subjects :
- Adult
Antibodies, Fungal blood
Antibodies, Fungal immunology
Antifungal Agents therapeutic use
Homozygote
Humans
Interleukin-17 blood
Lymphocyte Subsets immunology
Lymphocyte Subsets metabolism
Male
Mutation
Recurrence
Treatment Outcome
CARD Signaling Adaptor Proteins deficiency
Candida albicans
Candidiasis, Invasive drug therapy
Candidiasis, Invasive etiology
Granulocyte Colony-Stimulating Factor therapeutic use
Meningoencephalitis drug therapy
Meningoencephalitis etiology
Subjects
Details
- Language :
- English
- ISSN :
- 1532-0987
- Volume :
- 35
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- The Pediatric infectious disease journal
- Publication Type :
- Academic Journal
- Accession number :
- 26658378
- Full Text :
- https://doi.org/10.1097/INF.0000000000001028